260 related articles for article (PubMed ID: 10490596)
21. The inv(16) fusion protein associates with corepressors via a smooth muscle myosin heavy-chain domain.
Durst KL; Lutterbach B; Kummalue T; Friedman AD; Hiebert SW
Mol Cell Biol; 2003 Jan; 23(2):607-19. PubMed ID: 12509458
[TBL] [Abstract][Full Text] [Related]
22. The 12;21 translocation involving TEL and deletion of the other TEL allele: two frequently associated alterations found in childhood acute lymphoblastic leukemia.
Raynaud S; Cave H; Baens M; Bastard C; Cacheux V; Grosgeorge J; Guidal-Giroux C; Guo C; Vilmer E; Marynen P; Grandchamp B
Blood; 1996 Apr; 87(7):2891-9. PubMed ID: 8639909
[TBL] [Abstract][Full Text] [Related]
23. Multiple regions of ETO cooperate in transcriptional repression.
Hildebrand D; Tiefenbach J; Heinzel T; Grez M; Maurer AB
J Biol Chem; 2001 Mar; 276(13):9889-95. PubMed ID: 11150306
[TBL] [Abstract][Full Text] [Related]
24. Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia.
Golub TR; Barker GF; Bohlander SK; Hiebert SW; Ward DC; Bray-Ward P; Morgan E; Raimondi SC; Rowley JD; Gilliland DG
Proc Natl Acad Sci U S A; 1995 May; 92(11):4917-21. PubMed ID: 7761424
[TBL] [Abstract][Full Text] [Related]
25. Functional domains of the t(8;21) fusion protein, AML-1/ETO.
Lenny N; Meyers S; Hiebert SW
Oncogene; 1995 Nov; 11(9):1761-9. PubMed ID: 7478604
[TBL] [Abstract][Full Text] [Related]
26. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
Lo Coco F; Pisegna S; Diverio D
Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
[TBL] [Abstract][Full Text] [Related]
27. Small ubiquitin-like modifier conjugation regulates nuclear export of TEL, a putative tumor suppressor.
Wood LD; Irvin BJ; Nucifora G; Luce KS; Hiebert SW
Proc Natl Acad Sci U S A; 2003 Mar; 100(6):3257-62. PubMed ID: 12626745
[TBL] [Abstract][Full Text] [Related]
28. The MN1-TEL fusion protein, encoded by the translocation (12;22)(p13;q11) in myeloid leukemia, is a transcription factor with transforming activity.
Buijs A; van Rompaey L; Molijn AC; Davis JN; Vertegaal AC; Potter MD; Adams C; van Baal S; Zwarthoff EC; Roussel MF; Grosveld GC
Mol Cell Biol; 2000 Dec; 20(24):9281-93. PubMed ID: 11094079
[TBL] [Abstract][Full Text] [Related]
29. The t(8;21) fusion product, AML-1-ETO, associates with C/EBP-alpha, inhibits C/EBP-alpha-dependent transcription, and blocks granulocytic differentiation.
Westendorf JJ; Yamamoto CM; Lenny N; Downing JR; Selsted ME; Hiebert SW
Mol Cell Biol; 1998 Jan; 18(1):322-33. PubMed ID: 9418879
[TBL] [Abstract][Full Text] [Related]
30. Incidence and clinical relevance of TEL/AML1 fusion genes in children with acute lymphoblastic leukemia enrolled in the German and Italian multicenter therapy trials. Associazione Italiana Ematologia Oncologia Pediatrica and the Berlin-Frankfurt-Münster Study Group.
Borkhardt A; Cazzaniga G; Viehmann S; Valsecchi MG; Ludwig WD; Burci L; Mangioni S; Schrappe M; Riehm H; Lampert F; Basso G; Masera G; Harbott J; Biondi A
Blood; 1997 Jul; 90(2):571-7. PubMed ID: 9226156
[TBL] [Abstract][Full Text] [Related]
31. TEL contacts multiple co-repressors and specifically associates with histone deacetylase-3.
Wang L; Hiebert SW
Oncogene; 2001 Jun; 20(28):3716-25. PubMed ID: 11439334
[TBL] [Abstract][Full Text] [Related]
32. Correlation between cellular localization of TEL/AML1 fusion protein and repression of AML1-mediated transactivation of CR1 gene.
Rho JK; Kim JH; Yu J; Choe SY
Biochem Biophys Res Commun; 2002 Sep; 297(1):91-5. PubMed ID: 12220513
[TBL] [Abstract][Full Text] [Related]
33. Differential expression of TCL1 during pre-B-cell acute lymphoblastic leukemia progression.
Fears S; Chakrabarti SR; Nucifora G; Rowley JD
Cancer Genet Cytogenet; 2002 Jun; 135(2):110-9. PubMed ID: 12127395
[TBL] [Abstract][Full Text] [Related]
34. Frequency of ETV6/AML1 fusion in adult acute lymphoblastic leukemia.
Cuneo A; Agostini P; Vitale A; Foà R; Castoldi G
Leukemia; 2003 Feb; 17(2):476-7; author reply 477. PubMed ID: 12592356
[No Abstract] [Full Text] [Related]
35. Characterization of a novel ETS gene, TELB, encoding a protein structurally and functionally related to TEL.
Poirel H; Lopez RG; Lacronique V; Della Valle V; Mauchauffé M; Berger R; Ghysdael J; Bernard OA
Oncogene; 2000 Sep; 19(41):4802-6. PubMed ID: 11032031
[TBL] [Abstract][Full Text] [Related]
36. Minimal residual disease studies are beneficial in the follow-up of TEL/AML1 patients with B-precursor acute lymphoblastic leukaemia.
de Haas V; Oosten L; Dee R; Verhagen OJ; Kroes W; van den Berg H; van der Schoot CE
Br J Haematol; 2000 Dec; 111(4):1080-6. PubMed ID: 11167743
[TBL] [Abstract][Full Text] [Related]
37. Fluorescence in situ hybridization study of TEL/AML1 fusion and other abnormalities involving TEL and AML1 genes. Correlation with cytogenetic findings and prognostic value in children with acute lymphocytic leukemia.
Martínez-Ramírez A; Urioste M; Contra T; Cantalejo A; Tavares A; Portero JA; López-Ibor B; Bernacer M; Soto C; Cigudosa JC; Benítez J
Haematologica; 2001 Dec; 86(12):1245-53. PubMed ID: 11726315
[TBL] [Abstract][Full Text] [Related]
38. A mechanism of repression by acute myeloid leukemia-1, the target of multiple chromosomal translocations in acute leukemia.
Lutterbach B; Westendorf JJ; Linggi B; Isaac S; Seto E; Hiebert SW
J Biol Chem; 2000 Jan; 275(1):651-6. PubMed ID: 10617663
[TBL] [Abstract][Full Text] [Related]
39. Multiple subnuclear targeting signals of the leukemia-related AML1/ETO and ETO repressor proteins.
Barseguian K; Lutterbach B; Hiebert SW; Nickerson J; Lian JB; Stein JL; van Wijnen AJ; Stein GS
Proc Natl Acad Sci U S A; 2002 Nov; 99(24):15434-9. PubMed ID: 12427969
[TBL] [Abstract][Full Text] [Related]
40. High frequency of t(12;21) in childhood B-lineage acute lymphoblastic leukemia.
Romana SP; Poirel H; Leconiat M; Flexor MA; Mauchauffé M; Jonveaux P; Macintyre EA; Berger R; Bernard OA
Blood; 1995 Dec; 86(11):4263-9. PubMed ID: 7492786
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]